Electrical Stimulation in Patients With Unipolar Major Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Depression
Interventions
PROCEDURE

Stimulation of the trigeminal nerve (active stimulation)

"Participants will be randomized to active vs. sham stimulation during a period of 24 weeks with a one-way cross over at 12 weeks.~After 12 weeks, the participants receiving active electrical stimulation will continue under active stimulation until completion of the study.~Participants randomized to sham stimulation will be shifted to active stimulation and will be followed-up until completion of the study.~The study will be unblinded after 6 months of randomized stimulation. The second part of the study will be an open label prospective trial for evaluate long-term follow-up. The duration of the open label trial will be more 24 weeks."

PROCEDURE

Placebo stimulation of the trigeminal nerve (placebo)

"Participants will be randomized to active vs. sham stimulation during a period of 24 weeks with a one-way cross over at 12 weeks. Patients of the placebo group will be implanted with a lead in the V1 branch of the trigeminal nerve, but will not receive stimulation.~After 12 weeks, the participants receiving active electrical stimulation will continue under active stimulation until completion of the study.~Participants randomized to placebo stimulation will be shifted to active stimulation and will be followed-up until completion of the study.~The study will be unblinded after 6 months of randomized stimulation. The second part of the study will be an open label prospective trial for evaluate long-term follow-up. The duration of the open label trial will be more 24 weeks."

Trial Locations (1)

040005-000

Hospital do Coracao, São Paulo

All Listed Sponsors
lead

Hospital do Coracao

OTHER

NCT02239809 - Electrical Stimulation in Patients With Unipolar Major Depression | Biotech Hunter | Biotech Hunter